<?xml version="1.0" encoding="UTF-8"?>
<p>This work was supported through the Sub-Saharan African Network for TB/HIV Research Excellence (SANTHE), a DELTAS Africa Initiative [grant # DEL-15-006]. The DELTAS Africa Initiative is an independent funding scheme of the African Academy of Sciences (AAS)’s Alliance for Accelerating Excellence in Science in Africa (AESA) and supported by the New Partnership for Africa’s Development Planning and Coordinating Agency (NEPAD Agency) with funding from the Wellcome Trust [grant # 107752/Z/15/Z] and the UK government. The views expressed in this publication are those of the author(s) and not necessarily those of AAS, NEPAD Agency, Wellcome Trust, or the UK government. This research was also supported by the Poliomyelitis Research Foundation (PRF) of South Africa. M.T. is a SANTHE Postdoctoral Fellow. D. P. M. is supported by the National Research Foundation (NRF) of South Africa. T. d.O is supported by a South African Medical Research Council (SA MRC) Flagship grant (MRC-RFA-UFSP-01- 2013/UKZN HIVEPI) as well by an UK Royal Society Newton Advanced Fellowship. The authors declare that they have no competing interests.</p>
